Skip to contentS
Solid Biosciences Inc.
S
SLDBSolid Biosciences Inc. Released May 10, 2018, before the open
10-Q filed May 10, 2018, 40 days after period end · 0001193125-18-158375
Q1 2018 · 10-Q
Revenue$0.00$0.00— vs Q1 2017no prior Q4 2017 on file Net Income-$15.88M-$15.88M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
N/M vs Q4 2017
EPS Diluted-$0.54-$0.54N/M vs Q1 2017N/M vs Q4 2017 Operating Income-$15,973,000N/M Operating Cash Flow-$17,172,000N/M Free Cash Flowderived-$18,173,000N/M ended Mar 31, 2018 · filed May 10, 2018 · 40 d after period end